PDGFRA and neoplasm: Interestingly, depletion of MAP3K3, known to promote ovarian and NSCLC tumor growth (31, 32), inhibited PDGFRA mutant GIST cell viability; however, no selective small molecule inhibitors are currently available to explore targeting MAP3K3 in GISTs.